Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
Clinical trial NCT05104853 · COMPLETED
Trial details
- NCT number
- NCT05104853
- Sponsor
- COUR Pharmaceutical Development Company, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-25
- Primary completion
- 2026-01-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.